United Kingdom· GB-APID-39385311000001101
FEIBA 50units/ml (2,500unit) powder and 50ml solvent for solution for infusion vials
A medicinal product containing factor viii inhibitor bypassing fraction, registered in United Kingdom by Takeda UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Factor VIII Inhibitor Bypassing Fraction
- Manufacturer
- Takeda UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin00642621016994
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Factor viii inhibitor bypassing fraction in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandFeibaBaxalta Innovations GmbH
- SwedenFeiba 100 E/ml Pulver och vätska till infusionsvätska, lösningBaxalta Innovations GmbH
- CanadaFEIBA NFTAKEDA CANADA INC
- BelgiumFeiba 1000 UBaxalta Innovations
- IrelandFEIBA 100 U/ml powder and solvent for solution for infusionBaxalta Innovations GmbH
- NorwayFeibaBaxalta Innovations GmbH
- GermanyFeibaTakeda Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Feiba
- Belgium · Feiba
- Bulgaria · Фейба
- Cyprus · Feiba
- Czechia · Feiba
- Germany · Feiba
- Denmark · Feiba
- Estonia · Feiba
- Spain · Feiba
- Finland · Feiba
- France · Feiba
- Greece · Feiba
- Croatia · Feiba
- Hungary · Feiba Nf
- Ireland · Feiba
- Italy · Feiba
- Lithuania · Feiba
- Latvia · Feiba
- Malta · Feiba
- Netherlands · Feiba
- Norway · Feiba
- Poland · Feiba Nf
- Portugal · Feiba Nf
- Romania · Feiba
- Sweden · Feiba
- Slovenia · Feiba
- Slovakia · Feiba
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5ab4b7f-2a5c-40c0-af19-efec762ad33b GET /v1/drugs/f5ab4b7f-2a5c-40c0-af19-efec762ad33b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39385311000001101",
"desc": "FEIBA 50units/ml (2,500unit) powder and 50ml solvent for solution for infusion vials (Takeda UK Ltd)",
"form": "Powder and solvent for solution for infusion",
"vpid": "39389411000001106",
"source": "dmd",
"vtm_id": "774617003",
"strength": "2500 unit",
"substance": "Factor VIII Inhibitor Bypassing Fraction",
"ingredient": "Factor VIII inhibitor bypassing fraction",
"supplier_code": "3811601000001107"
}See everything about factor viii inhibitor bypassing fraction.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.